Efficacy, safety and cost-effectiveness of 40 mg versus 80 mg atorvastatin in a Sri Lankan cohort with acute coronary syndrome: a protocol for a single-centre randomised controlled clinical trial

Authors

Institutions

Publication Details

Journal
Trials
Published
2025-09-01
DOI
https://doi.org/10.1186/s13063-025-08943-2
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy, safety and cost-effectiveness of 40 mg versus 80 mg atorvastatin in a Sri Lankan cohort with acute coronary syndrome: a protocol for a single-centre randomised controlled clinical trial

K. Fernando, Chamila Mettananda, B. K. T. P. Dayanath, Chiranthi Welhenge et al.
Trials
Lipoproteins and Cardiovascular Health
article

Efficacy, safety and cost-effectiveness of 40 mg versus 80 mg atorvastatin in a Sri Lankan cohort with acute coronary syndrome: a protocol for a single-centre randomised controlled clinical trial

K. Fernando, Chamila Mettananda, B. K. T. P. Dayanath, Chiranthi Welhenge, Nilshan Fernando, Shamila De Silva, Shashima Liyanage
article en

Abstract

No abstract available for this paper.
TrialsVol. 26(1)
University of Kelaniya (LK), Colombo North Teaching Hospital (LK)
Openalex Percentile: Top 63%
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.